Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: Recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine

Medical Physics

Volumn 31, Issue 3, 2004, Pages 675-681

  DeWerd, Larry A ^a   Huq, M Saiful ^b,h   Das, Indra J ^c   Ibbott, Geoffrey S ^d   Hanson, William F ^d   Slowey, Thomas W ^e   Williamson, Jeffrey F ^f   Coursey, Bert M ^g  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e K and S Associates   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^h Calibration Lab Accreditation S

Author keywords

Brachytherapy; Dosimetry; Low dose rate sources

Indexed keywords

ACCREDITATION; CALIBRATION; DISEASES; ONCOLOGY; QUALITY ASSURANCE; RADIOTHERAPY;

BRACHYTHERAPY; CALIBRATION LABORATORIES; CLINICAL USERS; LOW DOSE RATE; LOW DOSE RATE BRACHYTHERAPY; NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY; PROSTATE CANCERS; PROVIDE GUIDANCES;

DOSIMETRY;

IODINE 125; PALLADIUM 103;

ACCREDITATION; BRACHYTHERAPY; CALIBRATION; DOSIMETRY; ENERGY; MEDICAL SOCIETY; PHOTON; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; REVIEW;

EID: 1642391493     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1645681     Document Type: Review

References (14)

1. J. C. Blasko, T. Mate, J. E. Sylvester, P. D. Grimm, and W. Cavanagh, "Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes," Semin Radiat. Oncol. 12, 81-94 (2002).
2. P. D. Grimm, J. C. Blasko, J. E. Sylvester, R. M. Meier, and W. Cavanagh," 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 51, 31-40 (2001).
3. J. C. Blasko, P. D. Grimm, J. E. Sylvester, K. R. Badiozamani, D. Hoak, and W. Cavanagh, "Palladium-103 brachytherapy for prostate carcinoma, " Int. J. Radiat. Oncol., Biol., Phys. 46, 839-850 (2000).
4. K. Wallner, G. Merrick, L. True, W. Cavanagh, C. Simpson, and W. Butler, "I-125 versus Pd-103 for low-risk prostate cancer: Morbidity outcomes from a prospective randomized multicenter trial," Cancer J. Sci. Am. 8, 67-73 (2002).
5. M. J. Zelefsky, T. Hollister, A. Raben, S. Matthews, and K. E. Wallner, "Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 47, 1261-1266 (2000).
6. R. Nath, L. L. Anderson, J. A. Meli, A. J. Olch, J. A. Stitt, and J. F. Williamson, "Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56," Med. Phys. 24, 1557-1598 (1997).
7. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43, " Med. Phys. 22, 209-234 (1995).
8. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, and R. Nath, "Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources," Med. Phys. 25, 2269-2270 (1998).
9. 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription," Med. Phys. 27, 634-642 (2000).
10. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, R. Nath, and G. Ibbott, "Guidance to users of Nycomed Amersham and North American Scientific Inc., I-125 intersitial sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry," Med. Phys. 26, 570-573 (1999).
11. A. V. D'Amico and N. J. Vogelzang, "Prostate brachytherapy: Increasing demand for the procedure despite the lack of standardized quality assurance and long-term outcome data," Cancer (N.Y.) 86, 1632-1634 (1999).
12. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, "Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations," Med. Phys. 31, 633-674 (2004).
13. L. A. DeWerd, "Brachytherapy dosimetric assessment: Source calibration," in Categorical Course in Brachytherapy Physics Syllabus, edited by B. Thomadsen (RSNA, Oak Brook, IL, 1997), pp. 143-153.
14. G. J. Kutcher, L. Coia, M. Gillin, W. Hanson, S. Leibel, R. J. Morton, J. R. Palta, J. A. Purdy, L. E. Reinstein, G. K. Svensson, M. Weller, and L. Wingfield, "Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40," Med. Phys. 21, 581-618 (1994).